Doloromics's core mission is to eradicate pain in patients who remain tragically underserved by current standards of care
Chronic pain patients are in desperate need of new treatments.
Our goal is to find better ways to treat their pain.
To achieve this goal we have created the largest single cell RNA sequencing database from human neuronal tissues.
To harness the power of this data we have developed a proprietary algorithm, DOLOReS, to analyze genomic sequencing data from human patients to identify non-opiate, novel drug targets for down-stream therapeutic development